Most sold healthcare stocks in Q2 2025
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2025, measured as net reductions in reported share positions from Q1 2025 into Q2 2025. Notable reductions at the top of this list include HALEON PLC-ADR (HLN), PFIZER INC (PFE), NEKTAR THERAPEUTICS (NKTR), ORGANON & CO (OGN). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| HLN | HALEON PLC-ADR | -6,896,872 | -$57.66M | 0 | 3 | 3 | 0 | 6 |
| PFE | PFIZER INC | -4,958,050 | -$138.81M | 0 | 3 | 8 | 3 | 12 |
| NKTR | NEKTAR THERAPEUTICS | -4,701,781 | -$3.20M | 0 | 0 | 0 | 1 | 0 |
| OGN | ORGANON & CO | -3,988,317 | -$77.63M | 0 | 1 | 1 | 1 | 2 |
| MYGN | MYRIAD GENETICS INC | -3,781,136 | -$37.82M | 0 | 1 | 1 | 0 | 2 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -3,629,813 | $117.36M | 1 | 0 | 2 | 0 | 4 |
| OSCR | OSCAR HEALTH INC - CLASS A | -3,605,554 | -$27.32M | 1 | 1 | 1 | 1 | 3 |
| OCGN | OCUGEN INC | -3,459,283 | -$2.44M | 0 | 0 | 0 | 1 | 0 |
| BMY | BRISTOL-MYERS SQUIBB CO | -3,251,847 | -$605.67M | 1 | 6 | 2 | 1 | 11 |
| BBIO | BRIDGEBIO PHARMA INC | -3,218,405 | $50.93M | 2 | 0 | 1 | 0 | 3 |
| ALHC | ALIGNMENT HEALTHCARE INC | -3,149,545 | -$70.18M | 0 | 1 | 0 | 1 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | -2,809,622 | -$58.13M | 0 | 0 | 1 | 1 | 1 |
| GILD | GILEAD SCIENCES INC | -2,388,013 | -$311.13M | 1 | 1 | 4 | 2 | 6 |
| CI | THE CIGNA GROUP | -2,303,711 | -$742.12M | 0 | 4 | 2 | 2 | 6 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,262,818 | -$160.41M | 1 | 2 | 2 | 0 | 7 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -2,221,998 | -$24.39M | 0 | 0 | 2 | 0 | 2 |
| CVS | CVS HEALTH CORP | -2,155,994 | -$27.52M | 1 | 4 | 7 | 0 | 13 |
| ENZ | ENZO BIOCHEM INC | -2,082,229 | -$770.42K | 0 | 0 | 0 | 1 | 0 |
| CERS | CERUS CORP | -2,051,438 | -$2.45M | 0 | 0 | 2 | 0 | 2 |
| SENS | SENSEONICS HOLDINGS INC | -1,971,632 | -$1.79M | 0 | 0 | 1 | 0 | 1 |
| RXRX | RECURSION PHARMACEUTICALS-A | -1,827,077 | -$17.26M | 0 | 0 | 2 | 0 | 2 |
| LYEL | LYELL IMMUNOPHARMA INC | -1,768,500 | -$951.45K | 0 | 0 | 0 | 1 | 0 |
| QSI | QUANTUM-SI INC | -1,535,321 | $4.28M | 0 | 0 | 2 | 0 | 2 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -1,534,323 | -$8.58M | 0 | 0 | 1 | 0 | 1 |
| HOLX | HOLOGIC INC | -1,353,821 | -$74.59M | 0 | 2 | 2 | 2 | 5 |
| SNY | SANOFI-ADR | -1,347,128 | -$596.31M | 1 | 3 | 2 | 0 | 6 |
| DVA | DAVITA INC | -1,345,795 | -$561.43M | 0 | 1 | 1 | 0 | 2 |
| TRVI | TREVI THERAPEUTICS INC | -1,284,392 | -$9.75M | 0 | 1 | 1 | 0 | 2 |
| IMVT | IMMUNOVANT INC | -1,269,327 | -$21.96M | 0 | 0 | 1 | 1 | 1 |
| NVRO | NEVRO CORP | -1,209,409 | -$7.06M | 0 | 0 | 0 | 1 | 0 |
| NVS | NOVARTIS AG-SPONSORED ADR | -1,158,647 | -$5.17M | 1 | 2 | 4 | 0 | 7 |
| KRON | KRONOS BIO INC | -1,102,326 | -$909.42K | 0 | 0 | 0 | 1 | 0 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -1,060,708 | $41.45M | 0 | 0 | 2 | 0 | 2 |
| OGI | ORGANIGRAM HOLDINGS INC | -1,004,748 | -$1.01M | 0 | 0 | 0 | 1 | 0 |
| A | AGILENT TECHNOLOGIES INC | -1,000,324 | -$111.69M | 0 | 1 | 3 | 0 | 5 |
| PRME | PRIME MEDICINE INC | -996,703 | -$761.33K | 0 | 0 | 2 | 0 | 2 |
| SOLV | SOLVENTUM CORP | -994,727 | $2.65M | 0 | 3 | 0 | 1 | 4 |
| VTYX | VENTYX BIOSCIENCES INC | -945,089 | -$1.02M | 0 | 0 | 1 | 0 | 1 |
| ABSI | ABSCI CORP | -909,161 | -$1.68M | 0 | 0 | 1 | 0 | 1 |
| RPTX | REPARE THERAPEUTICS INC | -900,285 | -$676.30K | 0 | 1 | 0 | 1 | 1 |
| ALLK | ALLAKOS INC | -869,311 | -$197.85K | 0 | 0 | 0 | 1 | 0 |
| WRBY | WARBY PARKER INC-CLASS A | -835,572 | $27.99M | 0 | 1 | 3 | 0 | 4 |
| PAHC | PHIBRO ANIMAL HEALTH CORP-A | -818,330 | -$14.93M | 0 | 0 | 1 | 1 | 1 |
| RLAY | RELAY THERAPEUTICS INC | -767,900 | -$745.00K | 0 | 0 | 1 | 0 | 1 |
| SYK | STRYKER CORP | -702,551 | -$38.42M | 0 | 2 | 5 | 0 | 7 |
| CMRX | CHIMERIX INC | -689,249 | -$5.87M | 0 | 0 | 0 | 1 | 0 |
| DCGO | DOCGO INC | -682,647 | -$2.20M | 0 | 0 | 1 | 1 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -678,575 | -$27.54M | 1 | 1 | 1 | 1 | 3 |
| RAPT | RAPT THERAPEUTICS INC | -648,823 | -$791.56K | 0 | 0 | 0 | 1 | 0 |
| ITCI | INTRA-CELLULAR THERAPIES INC | -621,200 | -$81.95M | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q2 2025
What are the most sold Healthcare stocks in Q2 2025?
The most sold healthcare stocks in Q2 2025 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q1 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2025?
Among the managers we track, net reductions were largest in companies such as HALEON PLC-ADR (HLN), PFIZER INC (PFE), NEKTAR THERAPEUTICS (NKTR), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2025).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.